New recombinant protein being mutant form of Tribolium castaneum procathepsin L, useful for e.g. producing recombinant mutant cathepsin L having postglutamine-cleavage activity and treating diseases associated with celiac disease
2023-06-13
专利权人FEDERAL STATE BUDGETARY EDUCATIONAL (BUDG-Non-standard)
申请日期2023-06-13
专利号RU2023115446-A
成果简介NOVELTY - A recombinant protein being a mutant form of Tribolium castaneumprocathepsin L having at least 92% homology with an amino acid sequence of SEQ ID NO: 1 (sequence not given in the specification), is new. The mutant procathepsin L is capable of generating active T.castaneumcathepsin L possessing postglutamine-cleavage activity through auto-processing. USE - The recombinant protein is useful for producing a recombinant mutant T.castaneumcathepsin L, hydrolyzing immunogenic gliadin peptides and treating diseases associated with celiac disease and enteropathology caused by gluten intolerance. The recombinant protein is useful as a therapeutic agent for celiac disease and gluten intolerance and producing gluten-free products (all claimed). ADVANTAGE - The recombinant protein produces acid resistant cathepsin L. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a method for producing a recombinant mutant T.castaneumcathepsin L, which involves performing an auto-processing of the above-mentioned mutant procathepsin L.
IPC 分类号C12N-009/82
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/21636
专题中国科学院新疆生态与地理研究所
作者单位
FEDERAL STATE BUDGETARY EDUCATIONAL (BUDG-Non-standard)
推荐引用方式
GB/T 7714
ELPIDINA E N,FILIPPOVA I YU,CHUGUNOV A O,et al. New recombinant protein being mutant form of Tribolium castaneum procathepsin L, useful for e.g. producing recombinant mutant cathepsin L having postglutamine-cleavage activity and treating diseases associated with celiac disease. RU2023115446-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。